XML 40 R28.htm IDEA: XBRL DOCUMENT v3.23.4
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2023
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended December 31, 

    

Six Months Ended December 31, 

    

2022

    

2023

2022

    

2023

Cost of goods sold

$

241

$

255

$

457

$

487

Selling, general and administrative

6,870

6,945

 

13,710

 

13,676

Research and development

128

128

 

249

 

254

Stock-based compensation expense

$

7,239

$

7,328

$

14,416

$

14,417

Schedule of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2023

 

83,677

 

$

87.09

 

Granted

 

22,438

119.45

Exercised

 

(14,489)

81.93

Expired or forfeited

 

(4,375)

$

86.09

Outstanding at December 31, 2023

 

87,251

$

96.32

7.7 years

$

2,856

Exercisable at December 31, 2023

42,856

 

6.1 years

$

1,797

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2023

 

455,515

$

85.15

Granted

 

331,278

95.23

Vested

 

(384,614)

79.51

Forfeited

 

(5,226)

84.66

Nonvested at December 31, 2023

 

396,953

$

99.03